Morten Herholdt
Stock Analyst at HSBC
(1.05)
# 3,771
Out of 5,182 analysts
16
Total ratings
36.36%
Success rate
-8.24%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $265 → $280 | $234.18 | +19.57% | 3 | Mar 17, 2026 | |
| LH Labcorp Holdings | Upgrades: Buy | n/a | $270.68 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $122.38 | +83.85% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $177.35 | +92.84% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $137.64 | -49.87% | 2 | Apr 24, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $324.63 | +66.34% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $67.12 | -22.53% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $176.46 | +47.34% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $355.30 | -9.94% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $1.30 | +792.31% | 1 | Sep 6, 2023 |
Johnson & Johnson
Mar 17, 2026
Maintains: Buy
Price Target: $265 → $280
Current: $234.18
Upside: +19.57%
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $270.68
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $122.38
Upside: +83.85%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $177.35
Upside: +92.84%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $137.64
Upside: -49.87%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $324.63
Upside: +66.34%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $67.12
Upside: -22.53%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $176.46
Upside: +47.34%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $355.30
Upside: -9.94%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.30
Upside: +792.31%